PYXS vs MTAC
Comparison between Pyxis Oncology Inc (PYXS, Company) and MedTech Acquisition Corp - Class A (MTAC, Company).
PYXS vs MTAC - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
PYXS
$183M
MTAC
$183M
Max Drawdown
PYXS
93.57%
Winner
MTAC
13.92%
Sharpe Ratio
Winner
PYXS
1.43
MTAC
0.44
5Y Beta
PYXS
1.32
MTAC
N/A
Industry
PYXS
Biotechnology
MTAC
N/A
P/E Ratio
PYXS
-2.23
Winner
MTAC
-32.94
Debt to Equity
PYXS
0.00%
MTAC
0.00%
Free Cash Flow Yield
PYXS
-36.51%
Winner
MTAC
-27.91%
P/S Ratio
PYXS
13.35
Winner
MTAC
12.43
P/B Ratio
PYXS
5.92
Winner
MTAC
-12.13
PYXS vs MTAC - Historical Returns
Returns include dividend reinvestment.
1M
Winner
PYXS
+15.59%
MTAC
+7.90%
3M
Winner
PYXS
+72.73%
MTAC
+9.99%
6M
Winner
PYXS
+104.03%
MTAC
+11.55%
1Y
Winner
PYXS
+176.36%
MTAC
+14.55%
5Y(CAGR)
PYXS
-26.27%
MTAC
N/A
Max(CAGR)
PYXS
-26.27%
Winner
MTAC
+3.05%
PYXS vs MTAC - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | PYXS | MTAC |
|---|---|---|
| 2026 | +164.35% | N/A |
| 2025 | -31.95% | N/A |
| 2024 | -24.27% | N/A |
| 2023 | +30.43% | +12.84% |
| 2022 | -88.28% | +0.80% |
| 2021 | -16.89% | -6.08% |
PYXS vs MTAC Drawdown Comparison
The maximum drawdown for PYXS was -93.57%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The maximum drawdown for MTAC was -13.92%, occurring on Mar 7, 2022. Recovery took 622 trading sessions.
The current PYXS drawdown is -77.71%.
| Rank | PYXS | MTAC |
|---|---|---|
| #1 | -93.57% Nov 4, 2021 - Apr 8, 2025 | -13.92% Feb 19, 2021 - Aug 10, 2023 |
| #2 | -12.95% Oct 8, 2021 - Oct 28, 2021 | -1.90% Feb 8, 2021 - Feb 16, 2021 |
| #3 | -1.05% Oct 29, 2021 - Nov 3, 2021 | N/A |
Correlation
Correlation between PYXS and MTAC is -0.20 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.20
-101
Select Stocks to Compare
Popular: PYXS vs SPYMTAC vs SPY
More Comparisons
Compare with similar stocks